| Name | Title | Contact Details |
|---|
Cisco Systems, Inc. is an American multinational technology conglomerate headquartered in San Jose, California, in the center of Silicon Valley.
Asterop is a San Francisco, CA-based company in the Computers & Electronics sector.
Endpoint Protector by CoSoSys is an advanced all-in-one DLP solution for Windows, macOS, and Linux, that puts an end to unintentional data leaks, protects from malicious data theft and offers seamless control of portable storage devices. Its content filtering capabilities for both data at rest and in motion range from predefined content based on dictionaries, regular expressions, and machine learning to profiles for data protection regulations such as GDPR, HIPAA, CCPA, PCI DSS, etc. Endpoint Protector was recognized in the 2017 Gartner Magic Quadrant for Enterprise Data Loss Prevention and the Radicati Group`s Enterprise Data Loss Prevention Market Quadrant 2017. It is certified with Common Criteria EAL2; won 2020, 2019, 2018 & 2017 Cybersecurity Excellence Awards in the DLP category and 2020, 2019 InfoSec Awards. CoSoSys distributes its products globally through partners, resellers, and directly to users through its online portal. The company enjoys an ever-expanding global userbase and was recognized in 2011 as one of the fastest-growing technology companies in Central Europe in the Deloitte Technology FAST 50 ranking.
Rubicon Global is North America`s leading provider of sustainable, cloud-based waste and recycling solutions. Through our innovative platform, companies can reduce operating expenses, divert waste from landfills, track key metrics and work towards long-term sustainability goals. Rubicon Global is disrupting an industry with misaligned incentives and empowering independent haulers and recyclers to grow their businesses. As a Certified B Corporation, Rubicon Global believes business is the most powerful way to create social and environmental change.
SolveBio equips you with Genomic Intelligence to guide you through a complex world towards innovation and discovery — driving precision medicine, advancing human health. Today, enterprises that endeavor to utilize genomics must navigate the ever-changing world of data, studies, and expert opinions. No matter the credibility of their sources or strength of their models, these will often conflict, simply because human biology and scientific discovery are dynamic and complex. To mainstream precision medicine, life science enterprises need to convert the complexity of biology into an easily distributed, readily deployed information asset. We call this Genomic Intelligence.